Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Geert D'Haens

1-50 of 199 results

View this query on the Wikidata Query Service
Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer

scientific article (publication date: 2 April 2009)
Infliximab, azathioprine, or combination therapy for Crohn's disease

article
Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial

scientific article published in February 2008
Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis

scientific article published on November 4, 2011
Adalimumab induction therapy for Crohn disease previously treated with infliximab: a randomized trial

scientific article published on 30 April 2007
Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn's disease

scientific article published on 8 October 2009
Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial

scientific article published on 05 January 2011
A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis

scientific article published on 20 December 2006
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations

scientific article
Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD

scientific article published on 01 October 2004
Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease

scientific article
Effectiveness of concomitant immunosuppressive therapy in suppressing the formation of antibodies to infliximab in Crohn's disease

scientific article
Adalimumab Induces and Maintains Mucosal Healing in Patients With Crohn's Disease: Data From the EXTEND Trial

scientific article published on February 8, 2012
Effects of Vedolizumab Induction Therapy for Patients With Crohn’s Disease in Whom Tumor Necrosis Factor Antagonist Treatment Failed

scientific article published on May 21, 2014
Withdrawal of immunosuppression in Crohn's disease treated with scheduled infliximab maintenance: a randomized trial

scientific article published on 8 March 2008
The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: when to start, when to stop, which drug to choose, and how to predict response?

scientific article
Development of the Crohn's disease digestive damage score, the Lémann score

scientific article published on 28 November 2010
Ornidazole for prophylaxis of postoperative Crohn's disease recurrence: a randomized, double-blind, placebo-controlled trial

scientific article
A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trial

scientific article
Randomized, double-blind comparison of 4 mg/kg versus 2 mg/kg intravenous cyclosporine in severe ulcerative colitis1 1Gert Van Assche, Severine Vermeire, Geert D’Haens, and Paul Rutgeerts have been instrumental in the design of the study, trial man

scientific article published on 01 October 2003
Effects of adalimumab therapy on incidence of hospitalization and surgery in Crohn's disease: results from the CHARM study

scientific article
Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis

scientific article published on May 2017
Adalimumab for the treatment of fistulas in patients with Crohn's disease

scientific article published on 06 February 2009
Therapy of Metronidazole With Azathioprine to Prevent Postoperative Recurrence of Crohn's Disease: A Controlled Randomized Trial

article by Geert R. D'Haens et al published October 2008 in Gastroenterology
The safety of vedolizumab for ulcerative colitis and Crohn's disease

scientific article
Omega-3 free fatty acids for the maintenance of remission in Crohn disease: the EPIC Randomized Controlled Trials

scientific article published on April 2008
Long-term outcome of treatment with intravenous cyclosporin in patients with severe ulcerative colitis

scientific article published in March 2004
Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 study

scientific article published on 12 April 2017
Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trial

scientific article published on 2 September 2015
Azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in Crohn's disease: a meta-analysis

scientific article published on 30 June 2009
Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial

scientific article published on 30 October 2017
A global consensus on the classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohn's disease.

scientific article
Ozanimod Induction and Maintenance Treatment for Ulcerative Colitis

scientific article
Budesonide in collagenous colitis: A double-blind placebo-controlled trial with histologic follow-up

scientific article published on January 1, 2002
Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study

scientific article published on 22 February 2013
Endoscopic improvement of mucosal lesions in patients with moderate to severe ileocolonic Crohn's disease following treatment with certolizumab pegol

scientific article published on 23 April 2012
Development of the Lémann index to assess digestive tract damage in patients with Crohn's disease.

scientific article published on 21 September 2014
The risk of post-operative complications associated with infliximab therapy for Crohn's disease: a controlled cohort study

scientific article published in April 2004
The role of centralized reading of endoscopy in a randomized controlled trial of mesalamine for ulcerative colitis

scientific article published on 22 March 2013
Certolizumab pegol for active Crohn's disease: a placebo-controlled, randomized trial

scientific article
Certolizumab pegol in patients with moderate to severe Crohn's disease and secondary failure to infliximab

scientific article published on 6 May 2010
Demographic and clinical parameters influencing the short-term outcome of anti-tumor necrosis factor (infliximab) treatment in Crohn's disease

scientific article published on 01 September 2002
Association between plasma concentrations of certolizumab pegol and endoscopic outcomes of patients with Crohn's disease

scientific article
The Value of Myenteric Plexitis to Predict Early Postoperative Crohn’s Disease Recurrence

scientific article published on 01 May 2006
Oral p38 mitogen-activated protein kinase inhibition with BIRB 796 for active Crohn's disease: a randomized, double-blind, placebo-controlled trial

scientific article published on 01 March 2006
Tofacitinib for induction and maintenance therapy of Crohn's disease: results of two phase IIb randomised placebo-controlled trials

scientific article published on 16 February 2017
Validation of endoscopic activity scores in patients with Crohn's disease based on a post hoc analysis of data from SONIC.

scientific article
Switch to adalimumab in patients with Crohn's disease controlled by maintenance infliximab: prospective randomised SWITCH trial

article by Gert Van Assche et al published 23 September 2011 in Gut
Endpoints for clinical trials evaluating disease modification and structural damage in adults with Crohn's disease

scientific article published on October 2009
A simple classification of Crohn's disease: Report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998

scientific article

Paulina is supported by:

About Paulina

Help